A Feasibility Study of Orchiectomy in Patients With Prostate Cancer on Chronic LHRH Agonist or Antagonist Therapy

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Diagnosis of metastatic prostatic adenocarcinoma

• Receiving luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy

• Able to complete written surveys in English

Locations
United States
Illinois
University of Chicago Medicine Comprehensive Cancer Center
RECRUITING
Chicago
Contact Information
Primary
Personalized Cancer Care Consortium
PhaseIICRA@medicine.bsd.uchicago.edu
773.702.1220
Time Frame
Start Date: 2020-12-18
Estimated Completion Date: 2025-12
Participants
Target number of participants: 100
Treatments
Experimental: Educational Intervention
Participants in this arm undergo a short educational session about orchiectomy. They will also be asked to complete questionnaires.
No_intervention: No Intervention
Participants that decline the education session will continue with routine care of their cancer.~They will also be asked to complete questionnaires.
Related Therapeutic Areas
Sponsors
Leads: University of Chicago

This content was sourced from clinicaltrials.gov